
Congressional disclosures
Thom Tillis
Republican · Senate · North Carolina · serving since 2015 · last filed 3 years ago
Recent disclosures
20 of 100 on record · traded Feb 13, 2015 to Aug 30, 2022Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 26, 2026), not the member's result. Not investment advice.
| Asset | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| KDSelfTechnology | Stock | Sale (Full) | $1,001 - $15,000 | +39.0%After the saleS&P 500 +90.9% · -51.9 pts vs S&P 500 | Aug 30, 2022 | Jul 15, 2023 | 319d |
| Victory Portfolio Munder Multi-Cap Mutual FundJointAs filed: Company: Munder Funds (Coloumbus, OH) | Fund | Sale (Full) | $1,001 - $15,000 | n/a | Dec 20, 2018 | Feb 27, 2019 | 69d |
| CVSJointHealthcare | Stock | Sale (Partial) | $1,001 - $15,000 | +40.6%After the saleS&P 500 +209.6% · -169.0 pts vs S&P 500 | Dec 20, 2018 | Feb 27, 2019 | 69d |
| Aquesta Financial Holdings, Inc.Joint | Stock | Sale (Full) | $1,001 - $15,000 | n/a | Feb 3, 2017 | Feb 17, 2017 | 14d |
| Aquesta Financial Holdings, Inc.Joint | Stock | Sale (Partial) | $15,001 - $50,000 | n/a | Feb 1, 2017 | Feb 17, 2017 | 16d |
| AQFH-Aquesta Financial Holdings, Inc.Joint | Stock | Sale (Partial) | $15,001 - $50,000 | n/a | Jan 26, 2017 | Feb 17, 2017 | 22d |
| BIOJointHealthcare | Stock | Sale (Full) | $1,001 - $15,000 | +212.6%After the saleS&P 500 +263.1% · -50.5 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| BERYJointConsumer Cyclical | Stock | Sale (Full) | $1,001 - $15,000 | +93.2%After the saleS&P 500 +164.8% · -71.6 pts vs S&P 500Price history ends Apr 29, 2025 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| DRQJointEnergy | Stock | Sale (Full) | $1,001 - $15,000 | -59.2%After the saleS&P 500 +262.3% · -321.5 pts vs S&P 500Now trading as INVX | Feb 13, 2015 | Feb 26, 2015 | 13d |
| TECHJointHealthcare | Stock | Sale (Full) | $1,001 - $15,000 | +206.7%After the saleS&P 500 +263.1% · -56.4 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| NICEJointTechnology | Stock | Sale (Full) | $1,001 - $15,000 | +123.2%After the saleS&P 500 +263.1% · -139.9 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| SIGISelective Insurance Group Inc. (NASDAQ)JointFinancial Services | Stock | Sale (Full) | $1,001 - $15,000 | +253.1%After the saleS&P 500 +263.1% · -10.0 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| TXRHJointConsumer Cyclical | Stock | Sale (Full) | $1,001 - $15,000 | +378.9%After the saleS&P 500 +263.1% · +115.8 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| CVLTJointTechnology | Stock | Sale (Full) | $1,001 - $15,000 | +287.8%After the saleS&P 500 +263.1% · +24.7 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| ROLLRBC Bearings Inc. (NASDAQ)JointIndustrials | Stock | Sale (Full) | $1,001 - $15,000 | +664.0%After the saleS&P 500 +262.3% · +401.7 pts vs S&P 500Now trading as RBC | Feb 13, 2015 | Feb 26, 2015 | 13d |
| GMEDJointHealthcare | Stock | Sale (Full) | $1,001 - $15,000 | +227.6%After the saleS&P 500 +263.1% · -35.5 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| SMTCJointTechnology | Stock | Sale (Full) | $1,001 - $15,000 | +386.7%After the saleS&P 500 +263.1% · +123.6 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| ALEJointUtilities | Stock | Sale (Full) | $1,001 - $15,000 | +26.6%After the saleS&P 500 +225.8% · -199.3 pts vs S&P 500Price history ends Dec 12, 2025 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| RBAJointIndustrials | Stock | Sale (Full) | $1,001 - $15,000 | +215.2%After the saleS&P 500 +263.1% · -47.9 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
| TCBIJointFinancial Services | Stock | Sale (Full) | $1,001 - $15,000 | +110.3%After the saleS&P 500 +263.1% · -152.9 pts vs S&P 500 | Feb 13, 2015 | Feb 26, 2015 | 13d |
No disclosures of that kind among the 20 rows shown.
Showing the 20 most recent disclosures. Lines for the same asset, day, band and action are shown once and marked with the number of lines. All of Thom Tillis' trades in the browser, every line of every report.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Under each figure: the S&P 500 over the same window, and the gap between the stock and the index in percentage points. A disclosure carries a band, not a fill. After a sale the stock's move keeps its sign, so a positive number means the stock kept rising after the sale. An option row carries the underlying stock's move, not the option's value. Where a ticker stopped trading the row says when its price history ends; where the company trades on under a new ticker the figure is priced under that one. Estimates; n/a where we hold no figure for the row.
Estimated portfolio
10 holdings · $1,000,001 - $5,000,000 in total · estimate, as of Oct 25, 2026| Holding | Estimated value | Share of portfolio |
|---|---|---|
| FBND | $250,001 - $500,000 | 18.4% |
| IWD | $250,001 - $500,000 | 17.5% |
| IEFA | $100,001 - $250,000 | 12.0% |
| IVV | $100,001 - $250,000 | 11.4% |
| IWF | $100,001 - $250,000 | 10.5% |
| IBM | $100,001 - $250,000 | 10.1% |
| IXN | $100,001 - $250,000 | 6.1% |
| IEMG | $100,001 - $250,000 | 5.5% |
| IWM | $50,001 - $100,000 | 4.7% |
| IWP | $50,001 - $100,000 | 3.9% |
All 10 estimated holdings. Every figure is an estimate built from the ranges on the member's financial disclosure reports, marked by the price movement of each stock since the filing; the share is of the whole estimated portfolio, small positions included. These are the stock and fund positions the model prices; the net worth estimate above also counts other disclosed assets and subtracts liabilities.
Year by year
buy volume against sale and exchange volume · range midpoints- Bought
- Sold or exchanged
- 2022Bought $0Sold or exchanged $8K
- 2021Bought $0Sold or exchanged $0
- 2020Bought $0Sold or exchanged $0
- 2019Bought $0Sold or exchanged $0
- 2018Bought $0Sold or exchanged $16K
- 2017Bought $0Sold or exchanged $73K
- 2016Bought $0Sold or exchanged $0
- 2015Bought $0Sold or exchanged $752K
- Bought
- Sold or exchanged
Disclosed volume per year the member traded, 2015 to 2022. A filing gives a range, not an amount, so each bar sums the midpoints of the ranges disclosed that year: a $1,001 to $15,000 line counts as $8,000. The sale side also counts exchanges, including shares received in a spin-off or merger.
Where the disclosed portfolio sits
share of the estimated portfolio- Funds & ETFs89.9%
- Technology10.1%
Questions
How many stock trades has Thom Tillis disclosed?
Thom Tillis has disclosed 100 transactions under the STOCK Act. This page lists the 20 most recent, covering Feb 13, 2015 to Aug 30, 2022.
How long does Thom Tillis take to report a trade?
For trades made from Feb 2015 to Aug 2022, the median gap between a trade and its disclosure is 13 days. The STOCK Act allows up to 45.
Which tickers does Thom Tillis trade most?
Among the 20 disclosures shown, the ticker that appears most is AQFH (3).
Which accounts do Thom Tillis's disclosures name?
Of the 20 disclosures shown, 19 name a joint account and 1 the member's own account. The account is whatever the filer wrote on the disclosure; a spouse's or a joint account is disclosed under the member's name, as the STOCK Act requires.
Where does the estimated net worth on this page come from?
A model's estimate, not a figure the member filed. Reports give every asset and debt as a range, so the model takes a value inside each range, subtracts debts and prices the stocks it tracks at the latest close we hold. We round it because the top range has no upper limit. It covers only what the reports carry and is not a measure of anyone's wealth. The methodology page sets out how it is built and what it leaves out.
How have the stocks moved since Thom Tillis's trades?
Across the 14 priced rows shown, the median stock move from the trade date to the latest close we hold (figures as of Oct 26, 2026) is +213.9%. 2 rows whose price history ends earlier are left out of it. That figure is an estimate describing the stock after each trade, not the member's result: a disclosure carries a band, not a fill, a sale keeps the same sign, and an option row carries the underlying stock's move. 4 of the rows shown have no figure in our data.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
A disclosure is a record of a transaction, not evidence of anything else, and nothing here is investment advice. Sourcing and the limits of this data are on the methodology page. How these reports work is explained in our guide to STOCK Act reports.
Data as of Oct 26, 2026.
